BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Machado A, Díaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, García ML, Sánchez-López E. Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021;13:1698. [PMID: 34683990 DOI: 10.3390/pharmaceutics13101698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Onugwu AL, Nwagwu CS, Onugwu OS, Echezona AC, Agbo CP, Ihim SA, Emeh P, Nnamani PO, Attama AA, Khutoryanskiy VV. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. J Control Release 2023;354:465-88. [PMID: 36642250 DOI: 10.1016/j.jconrel.2023.01.018] [Reference Citation Analysis]
2 Cao X, Ren Y, Lu Q, Wang K, Wu Y, Wang Y, Zhang Y, Cui XS, Yang Z, Chen Z. Lactoferrin: A glycoprotein that plays an active role in human health. Front Nutr 2022;9:1018336. [PMID: 36712548 DOI: 10.3389/fnut.2022.1018336] [Reference Citation Analysis]
3 Wang TZ, Liu XX, Wang SY, Liu Y, Pan XY, Wang JJ, Nan KH. Engineering Advanced Drug Delivery Systems for Dry Eye: A Review. Bioengineering (Basel) 2022;10. [PMID: 36671625 DOI: 10.3390/bioengineering10010053] [Reference Citation Analysis]
4 Ray Ong, Jillian Cornish, Jingyuan Wen. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review. Biometals 2022. [ DOI: 10.1007/s10534-022-00455-9] [Reference Citation Analysis]
5 Layús B, Gerez C, Rodriguez A. Development of an ophthalmic formulation with a postbiotic of Lactiplantibacillus plantarum CRL 759. Beneficial Microbes 2022. [DOI: 10.3920/bm2022.0044] [Reference Citation Analysis]
6 Das B, Nayak AK, Mallick S. Lipid-based nanocarriers for ocular drug delivery: An updated review. Journal of Drug Delivery Science and Technology 2022;76:103780. [DOI: 10.1016/j.jddst.2022.103780] [Reference Citation Analysis]
7 Thiruchenthooran V, Świtalska M, Bonilla L, Espina M, García ML, Wietrzyk J, Sánchez-lópez E, Gliszczyńska A. Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers. IJMS 2022;23:11310. [DOI: 10.3390/ijms231911310] [Reference Citation Analysis]
8 Shi L, Li T, Li L, Hou B. Research on mechanism of vitamin A combined with regenerated oxidation-reducing nanomedicine in treating rats with dry eye. mat express 2022;12:886-893. [DOI: 10.1166/mex.2022.2223] [Reference Citation Analysis]
9 Mohamed HB, Attia Shafie MA, Mekkawy AI. Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model. Pharmaceutics 2022;14:893. [DOI: 10.3390/pharmaceutics14050893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Mencucci R, Ghelardi E, Celandroni F, Mazzantini C, Vecchione A, Pellegrini-giampietro DE, Favuzza E, Landucci E. Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur® Citrus Extract. Ophthalmol Ther. [DOI: 10.1007/s40123-022-00492-0] [Reference Citation Analysis]
11 Galindo R, Sánchez-López E, Gómara MJ, Espina M, Ettcheto M, Cano A, Haro I, Camins A, García ML. Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation. Pharmaceutics 2022;14:285. [PMID: 35214019 DOI: 10.3390/pharmaceutics14020285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bonilla L, Espina M, Severino P, Cano A, Ettcheto M, Camins A, García ML, Souto EB, Sánchez-López E. Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 2021;14:90. [PMID: 35056986 DOI: 10.3390/pharmaceutics14010090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]